RNAZ icon

TransCode Therapeutics

17 hedge funds and large institutions have $7.28M invested in TransCode Therapeutics in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
17
Holders Change
+17
Holders Change %
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
ACM
1
AIGH Capital Management
Maryland
$3.8M 1,270,500 +1,270,500 New
KC
2
Kepos Capital
New York
$897K 300,000 +300,000 New
WVP
3
Worth Venture Partners
New Jersey
$884K 295,518 +295,518 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$598K 200,117 +200,117 New
Citadel Advisors
5
Citadel Advisors
Florida
$271K 90,774 +90,774 New
Two Sigma Investments
6
Two Sigma Investments
New York
$229K 76,645 +76,645 New
ACM
7
ACT Capital Management
Pennsylvania
$150K 50,000 +50,000 New
TSS
8
Two Sigma Securities
New York
$100K 33,314 +33,314 New
BRWA
9
B. Riley Wealth Advisors
Florida
$75K 25,000 +25,000 New
State Street
10
State Street
Massachusetts
$62K 20,600 +20,600 New
VF
11
Virtu Financial
New York
$54K 18,064 +18,064 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$50K 17,023 +17,023 New
BlackRock
13
BlackRock
New York
$49K 16,366 +16,366 New
SC
14
Shay Capital
New York
$45K 15,060 +15,060 New
UBS Group
15
UBS Group
Switzerland
$16K 5,337 +5,337 New
TRCT
16
Tower Research Capital (TRC)
New York
$4K 1,473 +1,473 New
CFGS
17
Concourse Financial Group Securities
Alabama
Wells Fargo
18
Wells Fargo
California
$0 38 +38 New